Portable powder delivery system and method
Abstract
A vehicle to carry a powered medication that addresses the limitations of the prior art. It includes a system and method. A powder delivery system includes a first panel and a second panel coupled together around a periphery of the panels to form a sealed void therebetween, each the panel having a width and length about equal to a standard credit card width and length, respectively; and a powder, disposed in the void, having a quantity at least about equal to an active dose of the powder, wherein a thickness of the panels with the powder disposed therebetween is not greater than about 0.1 inches and more preferably not greater than about 0.03 inches.
Claims
exact text as granted — not AI-modified1 .- 14 . (canceled)
15 . A powder medicine delivery system, comprising:
a first panel and a second panel coupled together around a periphery of said panels to form a sealed void therebetween; and a powder medicine, disposed in said void, having a quantity at least about equal to an active dose of said powder medicine; at least one additive disposed in said void with said powder medicine; wherein said panels are flexible and a thickness of said panels with said powder medicine disposed therebetween is not greater than about 0.1 inches, and wherein the panels with said powder medicine disposed therebetween have a length not greater than about 3⅜ inches and a width not greater than about 2⅛ inches.
16 . The powder delivery system of claim 15 wherein said panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof.
17 . The powder delivery system of claim 15 further comprising at least two tear-initiation notches for facilitating opening said sealed void to access said powder medicine disposed therein.
18 . The powder delivery system of claim 17 wherein said panels are generally waterproof.
19 . The powder delivery system of claim 15 wherein said dose is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof.
20 . The powder delivery system of claim 15 further comprising a detachable hangtag coupled to said coupled panels.
21 . The powder delivery system of claim 15 wherein a construction of said panels with said powder medicine disposed therebetween retains a flat profile that further resists premature access to said sealed void and exposure of said powder medicine responsive to compressive forces applied to said panels.
22 . A medicine powder delivery method, comprising:
(a) providing a sealed void by sealing edges of two powder contamination-resistant panels together, said panels having a length not greater than about 3⅜ inches and a width not greater than about 2⅛ inches; (b) providing a medicine powder within the sealed void; and (c) providing at least one additive in said void with said medicine powder, said panels with said medicine powder and said at least one additive disposed within said sealed void having a thickness not greater than about 0.1 inches, wherein said panels are resistant to tearing, puncturing, and moisture while being flexible and pliable and wherein a construction of said panels with said powder disposed therebetween retains a flat profile that further resists premature access to said sealed void and exposure of said medicine powder responsive to compressive forces applied to said panels.
23 . The method of claim 22 wherein said medicine powder is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof.
24 . A medication package, comprising:
a first flexible panel and a second flexible panel coupled together around a periphery of said flexible panels to form a sealed void therebetween; a powder medication disposed in said void, having a quantity at least about equal to an active dose of said powder medication; and at least one additive disposed in said void with said powder medication; wherein a thickness of the medication package with said powder medication and said at least one additive disposed therein is not greater than about 0.1 inches.
25 . The medication package of claim 24 wherein said first and second panels are resistant to tearing, puncturing, and moisture.
26 . The medication package of claim 24 wherein said first and second panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof.
27 . The medication package claim 24 wherein said dose is selected from one or more of group consisting of at least about 650 milligrams of a salicylate drug, at least about 150 milligrams of acetylsalicylic acid; at least about 250 milligrams of bismuth subsalicylate, at least about 500 milligrams of calcium carbonate; at least about 1 milligram loperamide HCl, at least about 25 milligrams diphenhydramine HCl, at least about 50 milligrams dimenhydrinate, at least about 200 milligrams non-steroidal anti-inflammatory drug, at least about 325 milligrams acetaminophen, at least about a medically significant dose of acetylsalicylic acid, acetaminophen and caffeine, and at least about a medically significant dose of sucrose, and combinations thereof.
28 . The method of claim 22 further comprising providing a detachable hangtag coupled to said coupled panels.
29 . The medication package of claim 24 wherein the panels have a width not greater than about 2⅛ inches and a length not greater than about 3⅜ inches.
30 . The medication package of claim 24 further comprising a detachable hangtag coupled to said coupled panels.
31 . The method of claim 22 wherein a quantity of said medicine powder is at least about equal to an active dose of said powder medicine.
32 . The method of claim 22 wherein said panels are made from one or more elements from the group consisting of mylar, foil, plastic, laminated paper, and combinations thereof.Join the waitlist — get patent alerts
Track US2017087090A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.